There was some information about this new drug, from the pharmaceutical company Abbott, that showed some promise, but I haven’t heard anything recently. The drug, called ABT-724, is similar to the ED drup apomorphine, which is sold in Europe as Uprima. However, Uprima hits a lot of dopamine receptors, including those that control nausea, so its use is limited. ABT-724, however, targets only one type of dopamine receptor, D4, which is involved in erection. So…it looked promising. Anyone heard about it? Let me know.

Here’s an article on it (LINK HERE) from The Proceedings of the National Academy of Sciences USA. Here is an article from Nature about ABT-724 (LINK HERE).